Zeitschriftenartikel zum Thema „PDE2A“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "PDE2A" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Skryabin, Egor B., Kirstie A. De Jong, Hariharan Subramanian, Nadja I. Bork, Alexander Froese, Boris V. Skryabin und Viacheslav O. Nikolaev. „CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms“. Cells 12, Nr. 11 (04.06.2023): 1543. http://dx.doi.org/10.3390/cells12111543.
Der volle Inhalt der QuelleIvey, F. Douglas, Lili Wang, Didem Demirbas, Christina Allain und Charles S. Hoffman. „Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases“. Journal of Biomolecular Screening 13, Nr. 1 (26.11.2007): 62–71. http://dx.doi.org/10.1177/1087057107312127.
Der volle Inhalt der QuelleManns, J. M., K. J. Brennan, S. B. Sheth und R. W. Colman. „Differential Regulation of Human Platelet Responses by cGMP Inhibited and Stimulated cAMP Phosphodiesterases“. Thrombosis and Haemostasis 87, Nr. 05 (2002): 873–79. http://dx.doi.org/10.1055/s-0037-1613099.
Der volle Inhalt der QuelleCarvalho, Thays Maria da Conceição Silva, Silvia Cardarelli, Mauro Giorgi, Andrea Lenzi, Andrea M. Isidori und Fabio Naro. „Phosphodiesterases Expression during Murine Cardiac Development“. International Journal of Molecular Sciences 22, Nr. 5 (05.03.2021): 2593. http://dx.doi.org/10.3390/ijms22052593.
Der volle Inhalt der QuelleChen, Ling, Suying Cui, Haiyang Yu, Gaowen Li, Na Liu, Qiang Wu, Han-Ting Zhang, James M. O’Donnell, Gang Wang und Ying Xu. „Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice“. Journal of Psychopharmacology 33, Nr. 5 (05.03.2019): 568–76. http://dx.doi.org/10.1177/0269881119832753.
Der volle Inhalt der QuelleChen, Lin, Jinchi Zhou, Zifeng Zhao, Yuhan Zhu, Jinliang Xing, Jiaze An und Xu Guo. „Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma“. Cells 12, Nr. 1 (23.12.2022): 68. http://dx.doi.org/10.3390/cells12010068.
Der volle Inhalt der QuelleBarbagallo, Federica, Valentina Rotilio, Maria Rita Assenza, Salvatore Aguanno, Tiziana Orsini, Sabrina Putti, Andrea M. Isidori et al. „PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis“. International Journal of Molecular Sciences 21, Nr. 8 (21.04.2020): 2902. http://dx.doi.org/10.3390/ijms21082902.
Der volle Inhalt der QuelleMatthiesen, Karina, und Jacob Nielsen. „Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity“. Biochemical Journal 423, Nr. 3 (12.10.2009): 401–9. http://dx.doi.org/10.1042/bj20090982.
Der volle Inhalt der QuelleRitawidya, Ludwig, Briel, Brust und Scheunemann. „Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors“. Molecules 24, Nr. 15 (31.07.2019): 2791. http://dx.doi.org/10.3390/molecules24152791.
Der volle Inhalt der QuelleRentsendorj, Otgonchimeg, Mahendra Damarla, Neil R. Aggarwal, Ji-Young Choi, Laura Johnston, Franco R. D'Alessio, Michael T. Crow und David B. Pearse. „Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury“. American Journal of Physiology-Lung Cellular and Molecular Physiology 301, Nr. 2 (August 2011): L161—L170. http://dx.doi.org/10.1152/ajplung.00073.2011.
Der volle Inhalt der QuelleJiang, Lei, und Shenghu Yan. „Prokaryotic Expression, Purification and Activity Detection of Phosphodiesterase 2A Protein“. Journal of Biology and Life Science 11, Nr. 2 (16.04.2020): 1. http://dx.doi.org/10.5296/jbls.v11i2.16650.
Der volle Inhalt der QuelleKubacka, Monika, Szczepan Mogilski, Marek Bednarski, Krzysztof Pociecha, Artur Świerczek, Noemi Nicosia, Jakub Schabikowski et al. „Antiplatelet Effects of Selected Xanthine-Based Adenosine A2A and A2B Receptor Antagonists Determined in Rat Blood“. International Journal of Molecular Sciences 24, Nr. 17 (29.08.2023): 13378. http://dx.doi.org/10.3390/ijms241713378.
Der volle Inhalt der QuelleWenzel, Barbara, Stefan R. Fritzsche, Magali Toussaint, Detlef Briel, Klaus Kopka, Peter Brust, Matthias Scheunemann und Winnie Deuther-Conrad. „Radiosynthesis and Preclinical Evaluation of an 18F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)“. Pharmaceuticals 15, Nr. 10 (15.10.2022): 1272. http://dx.doi.org/10.3390/ph15101272.
Der volle Inhalt der QuelleKallenborn-Gerhardt, Wiebke, Ruirui Lu, Aaron Bothe, Dominique Thomas, Jessica Schlaudraff, Jana E. Lorenz, Nancy Lippold et al. „Phosphodiesterase 2A Localized in the Spinal Cord Contributes to Inflammatory Pain Processing“. Anesthesiology 121, Nr. 2 (01.08.2014): 372–82. http://dx.doi.org/10.1097/aln.0000000000000270.
Der volle Inhalt der QuelleMaurin, Thomas, Francesca Melancia, Marielle Jarjat, Liliana Castro, Lara Costa, Sébastien Delhaye, Anouar Khayachi et al. „Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome“. Cerebral Cortex 29, Nr. 8 (23.08.2018): 3241–52. http://dx.doi.org/10.1093/cercor/bhy192.
Der volle Inhalt der QuelleXu, Ying, Jianchun Pan, Ling Chen, Chong Zhang, Jiao Sun, Jianxin Li, Linda Nguyen, Neetu Nair, Hanting Zhang und James M. O'Donnell. „Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway“. International Journal of Neuropsychopharmacology 16, Nr. 4 (01.05.2013): 835–47. http://dx.doi.org/10.1017/s146114571200065x.
Der volle Inhalt der QuelleRassi-Cruz, Marcela, Andrea G. Maria, Fabio R. Faucz, Edra London, Leticia A. P. Vilela, Lucas S. Santana, Anna Flavia F. Benedetti et al. „Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism“. Endocrine-Related Cancer 28, Nr. 1 (Januar 2021): 1–13. http://dx.doi.org/10.1530/erc-20-0384.
Der volle Inhalt der QuelleNakashima, Kosuke, und Hideki Matsui. „A Novel Inhibition Modality for Phosphodiesterase 2A“. SLAS DISCOVERY: Advancing the Science of Drug Discovery 25, Nr. 5 (28.04.2020): 498–505. http://dx.doi.org/10.1177/2472555220913241.
Der volle Inhalt der QuelleLi, Dan, Kun Liu, Harvey Davis, Calum Robertson, Oliver C. Neely, Adib Tarafdar, Ni Li, Konstantinos Lefkimmiatis, Manuela Zaccolo und David J. Paterson. „Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension“. Hypertension 79, Nr. 7 (Juli 2022): 1374–84. http://dx.doi.org/10.1161/hypertensionaha.121.18882.
Der volle Inhalt der QuelleRitawidya, Wenzel, Teodoro, Toussaint, Kranz, Deuther-Conrad, Dukic-Stefanovic, Ludwig, Scheunemann und Brust. „Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography“. Molecules 24, Nr. 22 (15.11.2019): 4149. http://dx.doi.org/10.3390/molecules24224149.
Der volle Inhalt der QuelleGong, Wei, Lei Yang, Yuanyuan Wang, Jianfeng Xian, Fuman Qiu, Li Liu, Mingzhu Lin, Yingyi Feng, Yifeng Zhou und Jiachun Lu. „Analysis of Survival-Related lncRNA Landscape Identifies A Role for LINC01537 in Energy Metabolism and Lung Cancer Progression“. International Journal of Molecular Sciences 20, Nr. 15 (01.08.2019): 3713. http://dx.doi.org/10.3390/ijms20153713.
Der volle Inhalt der QuelleLu, Jia Yang, und Marion B. Sewer. „p54nrb/NONO Regulates Cyclic AMP-Dependent Glucocorticoid Production by Modulating Phosphodiesterase mRNA Splicing and Degradation“. Molecular and Cellular Biology 35, Nr. 7 (20.01.2015): 1223–37. http://dx.doi.org/10.1128/mcb.00993-14.
Der volle Inhalt der QuelleKeefer, Christopher E., und George Chang. „The use of matched molecular series networks for cross target structure activity relationship translation and potency prediction“. MedChemComm 8, Nr. 11 (2017): 2067–78. http://dx.doi.org/10.1039/c7md00465f.
Der volle Inhalt der QuelleTanaka, Saori, Rina Tanaka, Saeko Harada, Yuka Kohda, Hitoshi Matsumura, Chikao Shimamoto, Yukinori Sawabe et al. „A PKG inhibitor increases Ca2+-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition“. American Journal of Physiology-Gastrointestinal and Liver Physiology 304, Nr. 9 (01.05.2013): G773—G780. http://dx.doi.org/10.1152/ajpgi.00281.2012.
Der volle Inhalt der QuelleDing, Hao, Xiao-Xing Xiong, Guan-Lan Fan, Yue-Xiong Yi, Yu-Rou Chen, Jing-Tao Wang und Wei Zhang. „The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining“. BioMed Research International 2020 (13.04.2020): 1–9. http://dx.doi.org/10.1155/2020/5478574.
Der volle Inhalt der QuelleRusswurm, Corina, Georg Zoidl, Doris Koesling und Michael Russwurm. „Dual Acylation of PDE2A Splice Variant 3“. Journal of Biological Chemistry 284, Nr. 38 (24.07.2009): 25782–90. http://dx.doi.org/10.1074/jbc.m109.017194.
Der volle Inhalt der QuelleWang, Jianjie, Susan Bingaman und Virginia H. Huxley. „Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases“. American Journal of Physiology-Heart and Circulatory Physiology 298, Nr. 4 (April 2010): H1146—H1154. http://dx.doi.org/10.1152/ajpheart.00252.2009.
Der volle Inhalt der QuelleSchmidt, Eric P., Mahendra Damarla, Otgonchimeg Rentsendorj, Laura E. Servinsky, Bing Zhu, Aigul Moldobaeva, Alfredo Gonzalez, Paul M. Hassoun und David B. Pearse. „Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice“. American Journal of Physiology-Lung Cellular and Molecular Physiology 295, Nr. 6 (Dezember 2008): L1056—L1065. http://dx.doi.org/10.1152/ajplung.90329.2008.
Der volle Inhalt der QuelleWang, Junnan, Mingyi Wu, Xiaowen Lin, Yun Li und Zhijian Fu. „Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-κB/p65 Signaling in Chronic Radiculitis Rats“. Pain Research and Management 2018 (13.12.2018): 1–8. http://dx.doi.org/10.1155/2018/5192814.
Der volle Inhalt der QuelleDurand, Julien, Antoine Lampron, Tania L. Mazzuco, Audrey Chapman und Isabelle Bourdeau. „Characterization of Differential Gene Expression in Adrenocortical Tumors Harboring β-Catenin (CTNNB1) Mutations“. Journal of Clinical Endocrinology & Metabolism 96, Nr. 7 (01.07.2011): E1206—E1211. http://dx.doi.org/10.1210/jc.2010-2143.
Der volle Inhalt der QuelleFryknäs, Mårten, Linda Rickardson, Malin Wickström, Sumeer Dhar, Henrik Lövborg, Joachim Gullbo, Peter Nygren, Mats G. Gustafsson, Anders Isaksson und Rolf Larsson. „Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model“. Journal of Biomolecular Screening 11, Nr. 5 (28.04.2006): 457–68. http://dx.doi.org/10.1177/1087057106288048.
Der volle Inhalt der QuelleJuilfs, D. M., W. K. Sonnenburg, S. Seraji, H.-I. Fülle, D. L. Garbers, M. D. Houslay und J. A. Beavo. „IDENTIFICATION OF A NEW PDE2A ISOFORM AND EXPRESSION OF PDE2 IN A SUBSET OF OLFACTORY NEURONS & GASTROINTESTINAL CELLS“. Biochemical Society Transactions 24, Nr. 4 (01.11.1996): 624S. http://dx.doi.org/10.1042/bst024624s.
Der volle Inhalt der QuelleMontoya-Durango, Diego, Mary Nancy Walter, Walter Rodriguez, Yali Wang, Julia H. Chariker, Eric C. Rouchka, Claudio Maldonado, Shirish Barve, Craig J. McClain und Leila Gobejishvili. „Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies“. Biology 12, Nr. 10 (10.10.2023): 1321. http://dx.doi.org/10.3390/biology12101321.
Der volle Inhalt der QuellePetersen, Tonny Studsgaard, Martin Stahlhut und Claus Yding Andersen. „Phosphodiesterases in the rat ovary: effect of cAMP in primordial follicles“. REPRODUCTION 150, Nr. 1 (Juli 2015): 11–20. http://dx.doi.org/10.1530/rep-14-0436.
Der volle Inhalt der QuelleMa, Y. S., Y. H. Xie, D. Ma, J. J. Zhang und H. J. Liu. „Shear stress-induced MMP1 and PDE2A expressions in coronary atherosclerosis“. Bratislava Medical Journal 122, Nr. 04 (2021): 287–92. http://dx.doi.org/10.4149/bll_2021_048.
Der volle Inhalt der QuelleDoummar, Diane, Christel Dentel, Romane Lyautey, Julia Metreau, Boris Keren, Nathalie Drouot, Ludivine Malherbe et al. „Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia“. European Journal of Human Genetics 28, Nr. 10 (28.05.2020): 1403–13. http://dx.doi.org/10.1038/s41431-020-0641-9.
Der volle Inhalt der QuelleAdderley, Shaquria P., Eileen A. Dufaux, Meera Sridharan, Elizabeth A. Bowles, Madelyn S. Hanson, Alan H. Stephenson, Mary L. Ellsworth und Randy S. Sprague. „Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans“. American Journal of Physiology-Heart and Circulatory Physiology 296, Nr. 5 (Mai 2009): H1617—H1624. http://dx.doi.org/10.1152/ajpheart.01226.2008.
Der volle Inhalt der QuelleTrabanco, Andrés A., Peter Buijnsters und Frederik J. R. Rombouts. „Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present)“. Expert Opinion on Therapeutic Patents 26, Nr. 8 (30.06.2016): 933–46. http://dx.doi.org/10.1080/13543776.2016.1203902.
Der volle Inhalt der QuelleFarmer, Reagan, Steven D. Burbano, Neema S. Patel, Angelo Sarmiento, Abigail J. Smith und Michy P. Kelly. „Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease“. Cellular Signalling 70 (Juni 2020): 109592. http://dx.doi.org/10.1016/j.cellsig.2020.109592.
Der volle Inhalt der QuelleFernández-Fernández, Diego, Holger Rosenbrock und Katja S. Kroker. „Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus“. Synapse 69, Nr. 10 (29.07.2015): 484–96. http://dx.doi.org/10.1002/syn.21840.
Der volle Inhalt der QuelleZlobin, Alexander S., Natalia A. Volkova, Natalia A. Zinovieva, Baylar S. Iolchiev, Vugar A. Bagirov, Pavel M. Borodin, Tatiana I. Axenovich und Yakov A. Tsepilov. „Loci Associated with Negative Heterosis for Viability and Meat Productivity in Interspecific Sheep Hybrids“. Animals 13, Nr. 1 (03.01.2023): 184. http://dx.doi.org/10.3390/ani13010184.
Der volle Inhalt der QuelleNaganawa, M., R. N. Waterhouse, N. Nabulsi, S. F. Lin, D. Labaree, J. Ropchan, S. Tarabar et al. „First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430“. Journal of Nuclear Medicine 57, Nr. 9 (21.04.2016): 1388–95. http://dx.doi.org/10.2967/jnumed.115.166850.
Der volle Inhalt der QuelleHaidar, Zahraa, Nadine Jalkh, Sandra Corbani, Joelle Abou‐Ghoch, Ali Fawaz, Cybel Mehawej und Eliane Chouery. „A Homozygous Splicing Mutation in PDE2A in a Family With Atypical Rett Syndrome“. Movement Disorders 35, Nr. 5 (20.03.2020): 896–99. http://dx.doi.org/10.1002/mds.28023.
Der volle Inhalt der QuelleWunder, Frank, Mark Jean Gnoth, Andreas Geerts und Daniel Barufe. „A Novel PDE2A Reporter Cell Line: Characterization of the Cellular Activity of PDE Inhibitors“. Molecular Pharmaceutics 6, Nr. 1 (02.12.2008): 326–36. http://dx.doi.org/10.1021/mp800127n.
Der volle Inhalt der QuelleSalpietro, Vincenzo, Belen Perez-Dueñas, Kosuke Nakashima, Victoria San Antonio-Arce, Andreea Manole, Stephanie Efthymiou, Jana Vandrovcova et al. „A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea“. Movement Disorders 33, Nr. 3 (02.02.2018): 482–88. http://dx.doi.org/10.1002/mds.27286.
Der volle Inhalt der QuelleClaire, Nicolas, Shittl Julia, Pertuiset Claire, Mehel Hind, Courilleau Delphine, Jullian Jean-Christophe, Cresteil Thierry et al. „0310 Assay development and high-throughput screening to identify PDE2A activators to treat heart failure“. Archives of Cardiovascular Diseases Supplements 6 (April 2014): 43. http://dx.doi.org/10.1016/s1878-6480(14)71379-5.
Der volle Inhalt der QuelleZhang, Zhao-Xiong, Qiang Han und Shu-Ye Liu. „Clinical significance of PDE2A in prognosis and immune infiltration in gastrointestinal cancer based on bioinformatics analysis“. World Chinese Journal of Digestology 29, Nr. 18 (28.09.2021): 1055–63. http://dx.doi.org/10.11569/wcjd.v29.i18.1055.
Der volle Inhalt der QuelleLi, San-Zhong, Kai-Xi Ren, Jing Zhao, Shuang Wu, Juan Li, Jian Zang, Zhou Fei und Jun-Long Zhao. „miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling“. International Journal of Biological Sciences 17, Nr. 13 (2021): 3508–21. http://dx.doi.org/10.7150/ijbs.62858.
Der volle Inhalt der QuelleSadhu, Krishna, Kelly Hensley, Vince A. Florio und Sharon L. Wolda. „Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells“. Journal of Histochemistry & Cytochemistry 47, Nr. 7 (Juli 1999): 895–905. http://dx.doi.org/10.1177/002215549904700707.
Der volle Inhalt der QuelleCann, M. J. „Sodium regulation of GAF domain function“. Biochemical Society Transactions 35, Nr. 5 (25.10.2007): 1032–34. http://dx.doi.org/10.1042/bst0351032.
Der volle Inhalt der Quelle